Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence (UCV/INCONTINEN)
Effect of a Peripheral and Central Neuromodulation Protocol Combined With the Application of Therapeutic Exercise in Patients Diagnosed With Urinary Incontinence. A Randomized Control Trial (RCT)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jesica L-G Leal García, PhD Student
- Phone Number: +34 657390304
- Email: jesica.leal@ucv.es
Study Contact Backup
- Name: Juan V-M Vicente Mampel, PhD
- Phone Number: +34 674177877
- Email: juan.vicente@ucv.es
Study Locations
-
-
-
Valencia, Spain, 46001
- Recruiting
- Catholic Univerity of Valencia
-
Contact:
- Jesica L-G Leal García, PhD Student
- Phone Number: +34 657390304
- Email: jesica.leal@ucv.es
-
Contact:
- Juan V-M Vicente Mampel, PhD
- Phone Number: +34 674177877
- Email: juan.vicente@ucv.es
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Present with a diagnosis of urinary incontinence or overactive bladder
- Women of menopausal age (>45 years)
- ≥3 months of duration
- Fulfill the established criteria for patient selection for neuromodulation treatment (urge urinary incontinence)
- Speak native Spanish or English
Exclusion Criteria:
- Prior or scheduled surgical procedures in the lumbar or abdominal region
- Presence of fractures or severe pathological conditions
- Current pregnancy or potential for pregnancy during the study period
- Neurological or psychiatric disorders
- Presence of stress urinary incontinence
- Female subjects with autoimmune diseases or malignancies
- Belonephobia
- Subjects who have undergone previous neuromodulation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Exercise + neuromodulation
The Intervention group will initially undergo posterior tibial nerve neuromodulation following a standardized protocol: 30 minutes per session, 2 sessions per week for 3 months.
Sessions will have a duration of 60 minutes and will be structured into three distinct blocks.
In the initial two treatment blocks, exercises will emphasize CORE stabilization and general strength training with forced exhalation to ensure appropriate activation of the transverse abdominal muscle, with the objective of preventing adverse effects associated with increased intra-abdominal pressure.
The third work block will focus on addressing anticipatory postural adjustment control, given its established relationship with the pelvic floor muscles.
This technique will be actively implemented in conjunction with the Proprioceptive Postural Reeducation Method (5P® LOGSURF).
|
A protocol of posterior tibial nerve electrostimulation will be implemented, inducing retrograde electrostimulation through the pelvic nerves, which are connected to the spinal cord via the sacral plexus at segments S2 and S3.
It is recommended to conduct an average of 10 sessions to evaluate the efficacy of the treatment, within a range of 6 to 16 sessions, each lasting 30 minutes, completing a treatment period of 3 months.
Participants will engage in a 60-minute exercise session, divided into two blocks: Block 1 will comprise 10 to 12 repetitions per set, aiming to achieve a perceived exertion level of 7 to 10 on the rating of perceived exertion (RPE).
Block 2 will utilize the 5P® LOGSURF Method, termed Proprioceptive Perineal Postural Reeducation, which employs unstable positions to promote postural adjustment and continuous balance.
This approach facilitates the activation of the abdominopelvic muscles, enhancing control and strengthening of the pelvic-perineal region.
|
|
Sham Comparator: Exercise+ ShamNeuromodulation
For the SHAM group, a non-penetrating needle with a retractable handle will be utilized, which is commonly employed in experimental research with Streitberger and Kleinhenz placebo needles.
This method creates the appearance of insertion without penetrating the skin and allows the needles to remain in situ for the duration of the intervention.
The SHAM group participants will adhere to the exercise protocol in the same manner as the intervention group.
|
Participants will engage in a 60-minute exercise session, divided into two blocks: Block 1 will comprise 10 to 12 repetitions per set, aiming to achieve a perceived exertion level of 7 to 10 on the rating of perceived exertion (RPE).
Block 2 will utilize the 5P® LOGSURF Method, termed Proprioceptive Perineal Postural Reeducation, which employs unstable positions to promote postural adjustment and continuous balance.
This approach facilitates the activation of the abdominopelvic muscles, enhancing control and strengthening of the pelvic-perineal region.
A needle with a retractable handle will be used, commonly employed in experimental research with Streitberger and Kleinhenz placebo needles.
This creates the appearance of insertion without penetrating the skin and allows the needles to remain in place for the duration of the intervention.
|
|
Active Comparator: Control Group
Conventional Physiotherapy.
The control group engages in specific pelvic floor exercises, which are less complex in terms of neuromuscular processing (focusing on fundamental spinal stimuli), in contrast to the more comprehensive and intricate tasks of the intervention group.
Additionally, manual therapy techniques are employed to inhibit trigger points in the musculature and ligamentous structures of the pelvic cavity, as well as intracavitary techniques aimed at alleviating mechanical pain.
|
Exercise The control group engages in specific pelvic floor exercises, which are less complex in terms of neuromuscular processing, such as Kegel's exercise.
The protocol for these exercises is standardized and conducted individually, comprising 8 to 12 sessions of 20-40 minutes each, performed twice weekly.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Overactive Bladder Questionnaire-Short Form
Time Frame: At baseline, Post1month, Post3months, Post6months
|
The Overactive Bladder Questionnaire-Short Form (OAB-q SF) is a concise, self-administered patient-reported outcomes instrument comprising two scales that assess symptom bother and health-related quality of life (HR-QOL) in patients with OAB.
This self-administered, disease-specific questionnaire evaluates symptomatic discomfort (6 items) and health-related quality of life (HRQoL, 13 items) using a 6-point Likert scale.
Scores are transformed to a 0-100 scale, where higher symptom scores indicate greater severity, and higher HRQoL scores reflect better quality of life
|
At baseline, Post1month, Post3months, Post6months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mapping of Incontinence Quality of Life (I-QOL)
Time Frame: at baseline, Post1month, Post3months, Post6months
|
Mapping of Incontinence Quality of Life (I-QOL) is a widely utilized self-reported health-related quality of life instrument for individuals with urinary incontinence (UI).
It comprises 22 items, each employing a 5-point ordinal response scale where 1 = extremely, 2 = quite a lot, 3 = moderately, 4 = a little, and 5 = not at all.
|
at baseline, Post1month, Post3months, Post6months
|
|
Bladder Diary
Time Frame: at baseline, Post1month, Post3months, Post6months
|
Bladder Diary is a non-invasive assessment tool that provides insights into bladder function.
It is utilized to measure the frequency and severity of urinary dysfunction symptoms, such as overactive bladder.
|
at baseline, Post1month, Post3months, Post6months
|
|
Urinary Incontinence Short Form (ICIQ-UI-SF)
Time Frame: at baseline, Post1month, Post3months, Post6months
|
Urinary Incontinence Short Form (ICIQ-UI-SF) comprises three components that assess subjective frequency, subjective severity, and quality of life through a self-administered questionnaire.
Questions 3 to 5 are scored items, with responses totaled to achieve a minimum score of 0 and maximum of 21.
|
at baseline, Post1month, Post3months, Post6months
|
|
Electromyography (EMG)
Time Frame: at baseline, Post1month, Post3months, Post6months
|
Electromyography (EMG) is a reliable, non-invasive method to assess pelvic floor muscle (PFM) tone, strength, endurance, and function.
Electrical activity is recorded using a vaginal probe to monitor deep and superficial PFM layers.
Measurements are obtained in supine and standing positions.
|
at baseline, Post1month, Post3months, Post6months
|
|
Oxford Scale
Time Frame: at baseline, Post1month, Post3months, Post6months
|
Oxford Scale is a subjective classification system utilized to evaluate the strength and quality of pelvic floor muscle (PFM) contractions through intracavitary palpation with one or two fingers.
The modified scale comprises 5 grades: 0 = no contraction; 1 = flickering muscle movements; 2 = weak contraction; 3 = increased pressure with slight muscle elevation; 4 = firm contraction with moderate elevation of the vaginal posterior wall; 5 = strong contraction with finger resistance against the abdominal wall.
|
at baseline, Post1month, Post3months, Post6months
|
|
Tampa Scale-11 (TSK-11)
Time Frame: at baseline, Post1month, Post3months, Post6months
|
Tampa Scale-11 (TSK-11) is a validated instrument for assessing kinesiophobia, or fear of movement, in individuals with chronic pain.
It identifies fear-avoidance beliefs with scores ranging from 11 to 44, where higher scores indicate greater fear of reinjury.
The TSK-11 demonstrates reliability (α = 0.84) and is widely employed in musculoskeletal pain populations.
|
at baseline, Post1month, Post3months, Post6months
|
|
Pain Catastrophizing Scale (PCS)
Time Frame: at baseline, Post1month, Post3months, Post6months
|
Pain Catastrophizing Scale (PCS) is a 13-item self-administered instrument assessing pain magnification, rumination, and helplessness.
Scores range from 13 to 62, with higher scores indicating greater catastrophizing.
The validated Spanish version exhibits high reliability (α = 0.95; test-retest r = 0.70-0.75).
|
at baseline, Post1month, Post3months, Post6months
|
|
Sport Injury Rehabilitation Adherence Scales (SIRAS)
Time Frame: at baseline, Post1month, Post3months, Post6months
|
Sport Injury Rehabilitation Adherence Scales (SIRAS) evaluates patient adherence during rehabilitation sessions, as rated by healthcare professionals.
It assesses the intensity with which patients complete exercises, their consistency in following instructions, and their receptiveness to program adjustments.
The scale comprises three items scored to produce a total between 0 and 15, with higher scores indicating greater adherence.
|
at baseline, Post1month, Post3months, Post6months
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Sonmez R, Yildiz N, Alkan H. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial. Ann Phys Rehabil Med. 2022 Jan;65(1):101486. doi: 10.1016/j.rehab.2021.101486. Epub 2021 Nov 11.
- Bo K, Berghmans LC. Nonpharmacologic treatments for overactive bladder-pelvic floor exercises. Urology. 2000 May;55(5A Suppl):7-11; discussion 14-6.
- Fuentes-Aparicio L, Arranz-Martin B, Navarro-Brazalez B, Bailon-Cerezo J, Sanchez-Sanchez B, Torres-Lacomba M. Postural Sensorimotor Control on Anorectal Pressures and Pelvic Floor Muscle Tone and Strength: Effects of a Single 5P(R) LOGSURF Session. A Cross-Sectional Preliminary Study. Int J Environ Res Public Health. 2021 Apr 2;18(7):3708. doi: 10.3390/ijerph18073708.
- Arlandis S, Ruiz MA, Errando C, Villacampa F, Arumi D, Lizarraga I, Rejas J. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form. Clin Drug Investig. 2012 Aug 1;32(8):523-32. doi: 10.2165/11633760-000000000-00000.
- Fernandez-Cuadros ME, Martin-Martin LM, Albaladejo-Florin MJ, Perez-Moro OS, Alava-Rabasa S, Goizueta-San-Martin G. [Transcutaneous stimulation of the posterior tibial nerve modifies the sympathetic skin response and improves overactive bladder syndrome: Case series and possible diagnostic test]. Rehabilitacion (Madr). 2022 Oct-Dec;56(4):255-263. doi: 10.1016/j.rh.2021.04.005. Epub 2021 Sep 24. Spanish.
- Abrams P. Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology. 2003 Nov;62(5 Suppl 2):28-37; discussion 40-2. doi: 10.1016/j.urology.2003.09.050.
- Carcelen-Fraile MDC, Aibar-Almazan A, Martinez-Amat A, Cruz-Diaz D, Diaz-Mohedo E, Redecillas-Peiro MT, Hita-Contreras F. Effects of Physical Exercise on Sexual Function and Quality of Sexual Life Related to Menopausal Symptoms in Peri- and Postmenopausal Women: A Systematic Review. Int J Environ Res Public Health. 2020 Apr 14;17(8):2680. doi: 10.3390/ijerph17082680.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Mental Disorders
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urination Disorders
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Behavioral Symptoms
- Elimination Disorders
- Urinary Bladder Diseases
- Urinary Incontinence
- Enuresis
- Urinary Bladder, Overactive
- Urinary Incontinence, Urge
Other Study ID Numbers
Other Study ID Numbers
- UCV/2024-2025/020
- Ethical Commithe (Other Identifier: FundacionUCV)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.